Absci evolves its board of directors with healthtech luminary frans van houten, former ceo of philips

Vancouver, wash., june 06, 2023 (globe newswire) -- absci (nasdaq: absi), a generative ai drug creation company, today announced the appointment of frans van houten to its board of directors. with his exceptional leadership experience and deep industry knowledge in the healthcare and technology industries, van houten will play a pivotal role in supporting absci's strategic vision and growth trajectory.
ABSI Ratings Summary
ABSI Quant Ranking